Biotech and Pharmaceuticals

Finance

‘This is the mental health moment’: Innovation and M&A are helping to boost these stocks to new heights

Two recent M&A announcements by big pharma are creating excitement among investors. Here's who is poised to benefit. Source link

Read More
Finance

What Eli Lilly investors can learn from the slow launch of a competitor’s drug

The rollout of Alzheimer's treatment Leqembi from Biogen is going slower than expected, providing a read-through for Club stock Eli

Read More
Finance

Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that

Novo Nordisk and Eli Lilly have given positive supply updates, aiming to reassure investors that they can continue to capitalize

Read More
Finance

Enphase CEO says solar industry poised to rebound on falling interest rates and rising utility costs

Enphase CEO Badri Kothandaraman has called a bottom in the first quarter and sees falling interest rates and rising utility

Read More
Finance

Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices

The CEOs of Merck, Johnson & Johnson and Bristol Myers Squibb will testify at the hearing on drug prices, Sen.

Read More
Finance

Humana stock plunges on dismal 2024 forecast, as insurers face soaring medical costs

The medical cost increases reflect an increasing number of older adults returning to hospitals to undergo procedures they had delayed

Read More